Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
PaperCitations, authors & open-access status
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,037 citations, 2016 year and bronze oa status.
2,037
Citations
2016
Year
bronze
OA Status